AIG
LGND icon

American International Group’s Ligand Pharmaceuticals LGND Stock Holding History

American International Group’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,062
Closed -$662K – 1485
2024
Q1 		$662K Sell
9,062
-82
-0.9% -$6.04K ﹤0.01% 1510
2023
Q4 		$653K Buy
9,144
+15
+0.2% +$885 ﹤0.01% 1515
2023
Q3 		$547K Buy
9,129
+192
+2% +$12.6K ﹤0.01% 1552
2023
Q2 		$644K Buy
8,937
+622
+7% +$46.7K ﹤0.01% 1492
2023
Q1 		$612K Buy
8,315
+30
+0.4% +$2.13K ﹤0.01% 1485
2022
Q4 		$553K Sell
8,285
-5,100
-38% -$332K ﹤0.01% 1534
2022
Q3 		$719K Buy
13,385
+46
+0.3% +$2.7K 0.01% 1368
2022
Q2 		$742K Sell
13,339
-711
-5% -$40.3K 0.01% 1370
2022
Q1 		$986K Sell
14,050
-850
-6% -$61.7K 0.01% 1343
2021
Q4 		$1.44M Sell
14,900
-479
-3% -$44.3K 0.01% 1221
2021
Q3 		$1.34M Sell
15,379
-45,253
-75% -$3.5M 0.01% 1266
2021
Q2 		$4.96K Sell
60,632
-787
-1% -$65.5K 0.02% 850
2021
Q1 		$5.84K Buy
61,419
+1,797
+3% +$170K 0.02% 774
2020
Q4 		$3.7K Sell
59,622
-1,109
-2% -$63.2K 0.01% 885
2020
Q3 		$3.61M Sell
60,731
-1,148
-2% -$78.3K 0.02% 794
2020
Q2 		$4.32M Sell
61,879
-5,530
-8% -$351K 0.02% 710
2020
Q1 		$3.06M Sell
67,409
-3,666
-5% -$208K 0.02% 761
2019
Q4 		$4.62M Sell
71,075
-5,648
-7% -$377K 0.02% 778
2019
Q3 		$4.76M Sell
76,723
-3,616
-5% -$227K 0.02% 732
2019
Q2 		$5.72M Sell
80,339
-5,841
-7% -$430K 0.02% 664
2019
Q1 		$6.76M Sell
86,180
-4,725
-5% -$358K 0.03% 599
2018
Q4 		$7.7M Buy
90,905
+64,537
+245% +$6.88M 0.03% 486
2018
Q3 		$4.51M Buy
26,368
+454
+2% +$68.4K 0.02% 808
2018
Q2 		$3.35M Buy
25,914
+4,908
+23% +$548K 0.01% 868
2018
Q1 		$2.16M Sell
21,006
-5,235
-20% -$518K 0.01% 958
2017
Q4 		$2.24M Buy
26,241
+141
+0.5% +$12.2K 0.01% 973
2017
Q3 		$2.22M Buy
26,100
+1,797
+7% +$142K 0.01% 951
2017
Q2 		$1.84M Buy
24,303
+5,798
+31% +$406K 0.01% 996
2017
Q1 		$1.22M Sell
18,505
-3,863
-17% -$254K ﹤0.01% 1112
2016
Q4 		$1.42M Sell
22,368
-319
-1% -$20.1K 0.01% 1054
2016
Q3 		$1.44M Sell
22,687
-8
-0% -$587 0.01% 1028
2016
Q2 		$1.69M Buy
22,695
+1,165
+5% +$86.5K 0.01% 955
2016
Q1 		$1.44M Buy
21,530
+996
+5% +$60.5K 0.01% 1264
2015
Q4 		$1.39M Buy
20,534
+238
+1% +$14.7K 0.01% 1281
2015
Q3 		$1.08M Buy
20,296
+246
+1% +$14.9K ﹤0.01% 1401
2015
Q2 		$1.26M Sell
20,050
-3,222
-14% -$176K 0.01% 1407
2015
Q1 		$1.12M Buy
23,272
+67
+0.3% +$2.57K ﹤0.01% 1521
2014
Q4 		$770K Sell
23,205
-1,970
-8% -$64.1K ﹤0.01% 1782
2014
Q3 		$738K Sell
25,175
-832
-3% -$27.6K ﹤0.01% 1797
2014
Q2 		$1.01M Buy
26,007
+2,606
+11% +$106K ﹤0.01% 1580
2014
Q1 		$982K Sell
23,401
-631
-3% -$26.3K ﹤0.01% 1537
2013
Q4 		$789K Buy
24,032
+4,889
+26% +$159K ﹤0.01% 1661
2013
Q3 		$517K Sell
19,143
-74
-0.4% -$2.08K ﹤0.01% 1945
2013
Q2 		$449K Buy
+19,217
New +$346K ﹤0.01% 1935

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

American International Group's LGND Position: Q2 2024 in Review

American International Group sold out of Ligand Pharmaceuticals (LGND) in Q2 2024, closing a stake of 9,062 shares — an estimated $662K sold.

American International Group first reported a position in LGND in Q2 2013 and held it in 44 quarters. The position peaked at $7.7M in Q4 2018. 234 funds tracked by Wall St. Rank hold LGND as of Q2 2024.

  • American International Group reported no remaining Ligand Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 9,062 Ligand Pharmaceuticals shares in Q2 2024, an estimated $662K.
  • American International Group first reported a position in Ligand Pharmaceuticals in Q2 2013 and held it in 44 quarters.
  • American International Group's Ligand Pharmaceuticals position peaked at $7.7M in Q4 2018.
  • 234 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.